Coronavirus India Russia covid-19 2020 vaccine Health Coronavirus India Russia

Dr Reddy's Lab shares surge on Russia covid vaccine agreement

₹4,631.55 on the BSE. On the NSE, it closed 4.17 per cent higher at ₹4,442.35.On August 11, the Sputnik V vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology was registered by the Ministry of Health of Russia and became the world's first registered vaccine against COVID-19 based on the human adenoviral vectors platform."Dr Reddys’ would carry out Phase 3 trials in India and, once approved, we understand opportunity can be large and result in one time revenue gain (if trials successful); albeit, there is no certainty on trial outcome and more importantly pricing would be keenly watched by govt.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News